Skip to main content

Table 4 Univariate and multivariate cox regression analysis of AFD, TMB and overall survival in patients with LUAD

From: Allele frequency deviation (AFD) as a new prognostic model to predict overall survival in lung adenocarcinoma (LUAD)

Variables

Patients (N)

Univariate analysis

Multivariate analysis

HR (95% CI)

P

HR (95% CI)

P

Training group

 Sex

Female/Male

27/27

1.581 (0.44–5.61)

0.47

0.33 (0.025–4.49)

0.40

 Age

 ≤ 60/ > 60

24/30

1.03 (0.96–1.10)

0.31

0.99 (0.91–1.079)

0.89

 Tumor_size

 ≤ 2/ > 2

28/27

1.279 (0.81–2.00)

0.28

1.2 (0.677–2.395)

0.45

 Smoking

N/(F/C)

36/18

0.467 (0.13–1.61)

0.22

0.20 (0.017–2.45)

0.21

 pT

T1/ T2

35/19

1.297 (0.366–4.6)

0.68

0.63 (0.104—3.7)

0.61

 TMB

 < 22/ ≥ 22

40/14

1.088 ( 0.96–1.23)

0.17

1.064 (0.90–1.25)

0.44

 AFD

 < 17.9 / ≥ 17.9

40/14

1.100 (1.008–1.2)

0.03

1.125 (1.001–1.26)

0.04

Validation group

 Sex

Female/Male

26/22

0.17 (0.021–1.48)

0.11

0.013 (0.003–0.46)

0.017

 Age

 ≤ 60/ > 60

19/29

0.97 (0.91–1.04)

0.48

0.975 (0.87–1.089)

0.65

 Tumor_size

 ≤ 2/ > 2

23/25

2.5 (1.15–5.54)

0.02

1.3 (0.25–6.61)

0.75

Smoking

N/(F/C)

35/13

0.87 (0.17–4.52)

0.87

0.06 (0.002–2.15)

0.12

 pT

T1/ T2/T4

32/15/1

1.52 (0.63–3.83)

0.37

3.5 (0.094–0.99)

0.49

 AFD

 < 16.76/ ≥ 16.76

36/12

3.1 (1.4–6.60)

0.003

4.62 (1.22–17.4)

0.02

  1. Bold values indicate the significant values < 0.05
  2. CI, confidence interval; C, current; F, Former; HR, hazard ratio; N, Never